TB-Related Articles

Updated February 3, 2023

2022 DTBE Publications

Althomsons SP, Winglee K, Heilig CM, Talarico S, Silk B, Wortham J, Hill AN, Navin TR. Using Machine Learning Techniques and National Tuberculosis Surveillance Data to Predict Excess Growth in Genotyped Tuberculosis Clusters. Am J Epidemiol. 2022 Jul 2:kwac117. doi: 10.1093/aje/kwac117. Epub ahead of print. PMID: 35780450.

Burzynski J, Mangan JM, Lam CK, Macaraig M, Salerno MM, deCastro BR, Goswami ND, Lin CY, Schluger NW, Vernon A; eDOT Study Team. In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence: A Randomized Noninferiority Trial. JAMA Netw Open. 2022 Jan 4;5(1):e2144210. doi: 10.1001/jamanetworkopen.2021.44210. PMID: 35050357; PMCID: PMC8777548.

Carr W, Kurbatova E, Starks A, Goswami N, Allen L, Winston C. Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis – United States, 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 25;71(8):285-289. doi: 10.15585/mmwr.mm7108a1. PMID: 35202353.

Deutsch-Feldman M, Springer YP, Felix D, Tsang CA, Brostrom R, Haddad M. Tuberculosis Among Native Hawaiian and Other Pacific Islander Persons: United States and U.S.-Affiliated Pacific Islands, 2010-2019. Health Equity. 2022 Jun 27;6(1):476-484. doi: 10.1089/heq.2022.0065. PMID: 35801148; PMCID: PMC9257550.

Filardo TD, Feng PJ, Pratt RH, Price SF, Self JL. Tuberculosis – United States, 2021. MMWR Morb Mortal Wkly Rep. 2022 Mar 25;71(12):441-446. doi: 10.15585/mmwr.mm7112a1. PMID: 35324877; PMCID: PMC8956339.

Goswami ND, Ashkin D, Haley CA; BAM Project Team. Pretomanid in the Treatment of Patients with Tuberculosis in the United States. N Engl J Med. 2022 Sep 1;387(9):850-852. doi: 10.1056/NEJMc2119461. PMID: 36053513.

Ho CS, Feng PJ, Narita M, Stout JE, Chen M, Pascopella L, Garfein R, Reves R, Katz DJ; Tuberculosis Epidemiologic Studies Consortium. Discordant results of tests for tuberculosis reconsidered – Authors’ reply. Lancet Infect Dis. 2022 Feb;22(2):164-165. doi: 10.1016/S1473-3099(21)00805-7. PMID: 35092787.

Holzman SB, Perry A, Saleeb P, Pyan A, Keh C, Salcedo K, Narita M, Ahmed A, Miller TL, Pettit AC, Khurana R, Whipple M, Katz D, Largen A, Krueger A, Shah M. Evaluation of the latent tuberculosis care cascade among public health clinics in the United States. Clin Infect Dis. 2022 Apr 1:ciac248. doi: 10.1093/cid/ciac248. Epub ahead of print. PMID: 35363249.

Holzman SB, Perry A, Keh C, Salcedo K, Narita M, Ahmed A, Katz D, Krueger A, Shah M. Reply to Gaskell, et al. Clin Infect Dis. 2022 Jul 23:ciac583. doi: 10.1093/cid/ciac583. Epub ahead of print. PMID: 35869850.

Kim S, Cohen T, Horsburgh CR, Miller JW, Hill AN, Marks SM, Li R, Kammerer JS, Salomon JA, Menzies NA. Trends, Mechanisms, and Racial/Ethnic Differences of Tuberculosis Incidence in the US-Born Population Aged 50 Years or Older in the United States. Clin Infect Dis. 2022 May 3;74(9):1594-1603. doi: 10.1093/cid/ciab668. PMID: 34323959; PMCID: PMC8799750.

Krugman J, Chorba T. When a Touch of Gold Was Used to Heal the King’s Evil. Emerg Infect Dis. 2022 Mar;28(3):765–7. doi: 10.3201/eid2803.AC2803. PMCID: PMC8888212.

Liu Y, Posey DL, Yang Q, Weinberg MS, Maloney SA, Lambert LA, Ortega LS, Marano N, Cetron MS, Phares CR. Multidrug-Resistant Tuberculosis in U.S.-Bound Immigrants and Refugees. Ann Am Thorac Soc. 2022 Jun;19(6):943-951. doi: 10.1513/AnnalsATS.202105-580OC. PMID: 34941475; PMCID: PMC9169124.

Pang AH, Green KD, Chandrika NT, Garzan A, Punetha A, Holbrook SYL, Willby MJ, Posey JE, Tsodikov OV, Garneau-Tsodikova S. Discovery of substituted benzyloxy-benzylamine inhibitors of acetyltransferase Eis and their anti-mycobacterial activity. Eur J Med Chem. 2022 Aug 18;242:114698. doi: 10.1016/j.ejmech.2022.114698. Epub ahead of print. PMID: 36037791.

Parmer J, Macario E, Tatum K, Brackett A, Allen L, Picard R, DeLuca N, Dowling M. Latent tuberculosis infection: Misperceptions among non-U.S.-born-populations from countries where tuberculosis is common. Glob Public Health. 2022 Aug;17(8):1728-1742. doi: 10.1080/17441692.2021.1947342. Epub 2021 Jul 6. PMID: 34228584; PMCID: PMC8733044.

Pettit AC, Phillips PP, Kurbatova E, Vernon A, Nahid P, Dawson R, Dooley KE, Sanne I, Waja Z, Mohapi L, Podany AT, Samaneka W, Savic RM, Johnson JL, Muzanyi G, Lalloo UG, Bryant K, Sizemore E, Scott N, Dorman SE, Chaisson RE, Swindells S; Tuberculosis Trials Consortium (TBTC) Study 31/AIDS Clinical Trials Group (ACTG) A5349 study team. Rifapentine with and without moxifloxacin for pulmonary tuberculosis in people with HIV (S31/A5349). Clin Infect Dis. 2022 Aug 30:ciac707. doi: 10.1093/cid/ciac707. Epub ahead of print. PMID: 36041016.

Phares CR, Liu Y, Wang Z, Posey DL, Lee D, Jentes ES, Weinberg M, Mitchell T, Stauffer W, Self JL, Marano N. Disease Surveillance Among U.S.-Bound Immigrants and Refugees – Electronic Disease Notification System, United States, 2014-2019. MMWR Surveill Summ. 2022 Jan 21;71(2):1-21. doi: 10.15585/mmwr.ss7102a1. PMID: 35051136; PMCID: PMC8791661.

Phillips PPJ, Kurbatova EV, Dorman SE. Four-Month Rifapentine Regimens for Tuberculosis. Reply. N Engl J Med. 2022 Mar 17;386(11):1095-1096. doi: 10.1056/NEJMc2114483. PMID: 35294823.

Raz KM, Talarico S, Althomsons SP, Kammerer JS, Cowan LS, Haddad MB, McDaniel CJ, Wortham JM, France AM, Powell KM, Posey JE, Silk BJ. Molecular surveillance for large outbreaks of tuberculosis in the United States, 2014-2018. Tuberculosis (Edinb). 2022 Aug 9;136:102232. doi: 10.1016/j.tube.2022.102232. Epub ahead of print. PMID: 35969928.
PMID: 35969928.

Schwartz NG, Hernandez-Romieu AC, Annambhotla P, Filardo TD, Althomsons SP, Free RJ, Li R, Wyatt Wilson W, Deutsch-Feldman M, Drees M, Hanlin E, White K, Lehman KA, Thacker TC, Brubaker SA, Clark B, Basavaraju SV, Benowitz I, Burton Glowicz J, Cowan LS, Starks AM, Bamrah Morris S, LoBue P, Stewart RJ, Wortham JM, Haddad MB; Bone Allograft Tuberculosis Investigators. Nationwide tuberculosis outbreak in the USA linked to a bone graft product: an outbreak report. Lancet Infect Dis. 2022 Aug 4:S1473-3099(22)00425-X. doi: 10.1016/S1473-3099(22)00425-X. Epub ahead of print. PMID: 35934016.

Shrestha S, Winglee K, Hill A, Shaw T, Smith J, Kammerer JS, Silk BJ, Marks S, Dowdy D. Model-based analysis of tuberculosis genotype clusters in the United States reveals high degree of heterogeneity in transmission, and state-level differences across California, Florida, New York, and Texas. Clin Infect Dis. 2022 Feb 10:ciac121. doi: 10.1093/cid/ciac121. Epub ahead of print. PMID: 35143641.

Smith J, Cohen T, Dowdy D, Shrestha S, Gandhi NR, Hill AN. Quantifying Mycobacterium tuberculosis transmission dynamics across global settings: a systematic analysis. Am J Epidemiol. 2022 Oct 13:kwac181. doi: 10.1093/aje/kwac181. Epub ahead of print. PMID: 36227246.

Smith JP, Modongo C, Moonan PK, Dima M, Matsiri O, Fane O, Click ES, Boyd R, Finlay A, Surie D, Tobias JL, Zetola NM, Oeltmann JE. Tuberculosis attributed to transmission within healthcare facilities, Botswana-The Kopanyo Study. Infect Control Hosp Epidemiol. 2022 Apr 6:1-7. doi: 10.1017/ice.2021.517. Epub ahead of print. PMID: 35382909.

Smith JP, Oeltmann JE, Hill AN, Tobias JL, Boyd R, Click ES, Finlay A, Mondongo C, Zetola NM, Moonan PK. Characterizing tuberculosis transmission dynamics in high-burden urban and rural settings. Sci Rep. 2022 Apr 26;12(1):6780. doi: 10.1038/s41598-022-10488-2. PMID: 35474076; PMCID: PMC9042872.

Stewart RJ, Raz KM, Burns SP, Kammerer JS, Haddad MB, Silk BJ, Wortham JM. Tuberculosis Outbreaks in State Prisons, United States, 2011-2019. Am J Public Health. 2022 Aug;112(8):1170-1179. doi: 10.2105/AJPH.2022.306864. PMID: 35830666.

Tasneen R, Garcia A, Converse PJ, Zimmerman MD, Dartois V, Kurbatova E, Vernon AA, Carr W, Stout JE, Dooley KE, Nuermberger EL. Novel Regimens of Bedaquiline-Pyrazinamide Combined with Moxifloxacin, Rifabutin, Delamanid and/or OPC-167832 in Murine Tuberculosis Models. Antimicrob Agents Chemother. 2022 Mar 22:e0239821. doi: 10.1128/aac.02398-21. Epub ahead of print. PMID: 35315690.

Tsang CA, Patel NN, Stout JE, Fernando R, Pratt R, Goswami ND. Factors Associated With Receiving Longer Than Recommended Therapy Among Culture-Negative Pulmonary Tuberculosis Patients. Open Forum Infect Dis. 2022 Nov 21;9(12):ofac630. doi: 10.1093/ofid/ofac630. PMID: 36519121; PMCID: PMC9745766.

Walker WL, Schmit KM, Welch EC, Vonnahme LA, Talwar A, Nguyen M, Stojanovic D, Langer AJ, Cocoros NM. Using the Food and Drug Administration´s Sentinel System for surveillance of TB infection. Int J Tuberc Lung Dis. 2022 Dec 1;26(12):1170-1176. doi: 10.5588/ijtld.22.0259. PMID: 36447322.

Wang Z, Posey DL, Brostrom RJ, Morris SB, Marano N, Phares CR. Post-Arrival Evaluation of Immigrant and Refugee Children in the USA with Latent Tuberculosis Infection Diagnosed Overseas, 2007‒2019. J Pediatr. 2022 Feb 1:S0022-3476(22)00080-4. doi: 10.1016/j.jpeds.2022.01.049. Epub ahead of print. PMID: 35120982.

Winglee K, Hill AN, Belknap R, Stout JE, Ayers T. Variability of interferon-γ release assays in people at high risk of tuberculosis infection or progression to tuberculosis disease living in the United States. Clin Microbiol Infect. 2022 Feb 17:S1198-743X(22)00094-5. doi: 10.1016/j.cmi.2022.02.020. Epub ahead of print. PMID: 35183749.

Winglee K, Hill AN, Langer AJ, Self JL. Decrease in Tuberculosis Cases during COVID-19 Pandemic as Reflected by Outpatient Pharmacy Data, United States, 2020. Emerg Infect Dis. 2022 Apr;28(4):820-827. doi: 10.3201/eid2804.212014. PMID: 35318920; PMCID: PMC8962886.